nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—CYP1A2—Estropipate—osteoporosis	0.123	0.53	CbGbCtD
Tizanidine—CYP1A2—Conjugated Estrogens—osteoporosis	0.058	0.251	CbGbCtD
Tizanidine—CYP1A2—Estradiol—osteoporosis	0.0509	0.22	CbGbCtD
Tizanidine—Haemoglobin—Estradiol—osteoporosis	0.000462	0.000667	CcSEcCtD
Tizanidine—Infection—Pamidronate—osteoporosis	0.000461	0.000665	CcSEcCtD
Tizanidine—Rhinitis—Estradiol—osteoporosis	0.00046	0.000665	CcSEcCtD
Tizanidine—Urticaria—Calcitriol—osteoporosis	0.00046	0.000665	CcSEcCtD
Tizanidine—Haemorrhage—Estradiol—osteoporosis	0.000459	0.000663	CcSEcCtD
Tizanidine—Hepatitis—Estradiol—osteoporosis	0.000459	0.000663	CcSEcCtD
Tizanidine—Abdominal pain—Calcitriol—osteoporosis	0.000458	0.000661	CcSEcCtD
Tizanidine—Body temperature increased—Calcitriol—osteoporosis	0.000458	0.000661	CcSEcCtD
Tizanidine—Shock—Pamidronate—osteoporosis	0.000456	0.000659	CcSEcCtD
Tizanidine—Loss of consciousness—Zoledronate—osteoporosis	0.000456	0.000659	CcSEcCtD
Tizanidine—Pharyngitis—Estradiol—osteoporosis	0.000456	0.000658	CcSEcCtD
Tizanidine—Hypersensitivity—Estropipate—osteoporosis	0.000455	0.000657	CcSEcCtD
Tizanidine—Nervous system disorder—Pamidronate—osteoporosis	0.000455	0.000657	CcSEcCtD
Tizanidine—Thrombocytopenia—Pamidronate—osteoporosis	0.000454	0.000656	CcSEcCtD
Tizanidine—Urinary tract disorder—Estradiol—osteoporosis	0.000454	0.000655	CcSEcCtD
Tizanidine—Vomiting—Etidronic acid—osteoporosis	0.000454	0.000655	CcSEcCtD
Tizanidine—Tachycardia—Pamidronate—osteoporosis	0.000452	0.000654	CcSEcCtD
Tizanidine—Connective tissue disorder—Estradiol—osteoporosis	0.000451	0.000652	CcSEcCtD
Tizanidine—Urethral disorder—Estradiol—osteoporosis	0.00045	0.00065	CcSEcCtD
Tizanidine—Rash—Etidronic acid—osteoporosis	0.00045	0.00065	CcSEcCtD
Tizanidine—Convulsion—Zoledronate—osteoporosis	0.00045	0.000649	CcSEcCtD
Tizanidine—Dermatitis—Etidronic acid—osteoporosis	0.000449	0.000649	CcSEcCtD
Tizanidine—Vertigo—Conjugated Estrogens—osteoporosis	0.000449	0.000648	CcSEcCtD
Tizanidine—Hyperhidrosis—Pamidronate—osteoporosis	0.000448	0.000647	CcSEcCtD
Tizanidine—Syncope—Conjugated Estrogens—osteoporosis	0.000448	0.000647	CcSEcCtD
Tizanidine—Hypertension—Zoledronate—osteoporosis	0.000448	0.000647	CcSEcCtD
Tizanidine—Hypersensitivity—Alendronate—osteoporosis	0.000448	0.000647	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000444	0.000642	CcSEcCtD
Tizanidine—Asthenia—Estropipate—osteoporosis	0.000443	0.000639	CcSEcCtD
Tizanidine—Arthralgia—Zoledronate—osteoporosis	0.000442	0.000638	CcSEcCtD
Tizanidine—Anxiety—Zoledronate—osteoporosis	0.00044	0.000636	CcSEcCtD
Tizanidine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000439	0.000634	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000439	0.000634	CcSEcCtD
Tizanidine—Paraesthesia—Risedronate—osteoporosis	0.000438	0.000632	CcSEcCtD
Tizanidine—Pruritus—Estropipate—osteoporosis	0.000437	0.000631	CcSEcCtD
Tizanidine—Discomfort—Zoledronate—osteoporosis	0.000436	0.00063	CcSEcCtD
Tizanidine—Asthenia—Alendronate—osteoporosis	0.000436	0.00063	CcSEcCtD
Tizanidine—Hypersensitivity—Ibandronate—osteoporosis	0.000436	0.00063	CcSEcCtD
Tizanidine—Dyspnoea—Risedronate—osteoporosis	0.000435	0.000628	CcSEcCtD
Tizanidine—Erythema multiforme—Estradiol—osteoporosis	0.000434	0.000627	CcSEcCtD
Tizanidine—Hypotension—Pamidronate—osteoporosis	0.000433	0.000626	CcSEcCtD
Tizanidine—Convulsion—Conjugated Estrogens—osteoporosis	0.000433	0.000625	CcSEcCtD
Tizanidine—Dry mouth—Zoledronate—osteoporosis	0.000432	0.000624	CcSEcCtD
Tizanidine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000431	0.000623	CcSEcCtD
Tizanidine—Pruritus—Alendronate—osteoporosis	0.00043	0.000621	CcSEcCtD
Tizanidine—Dyspepsia—Risedronate—osteoporosis	0.000429	0.00062	CcSEcCtD
Tizanidine—Tinnitus—Estradiol—osteoporosis	0.000428	0.000619	CcSEcCtD
Tizanidine—Constipation—Ethinyl Estradiol—osteoporosis	0.000428	0.000618	CcSEcCtD
Tizanidine—Confusional state—Zoledronate—osteoporosis	0.000427	0.000617	CcSEcCtD
Tizanidine—Hypersensitivity—Calcitriol—osteoporosis	0.000427	0.000616	CcSEcCtD
Tizanidine—Cardiac disorder—Estradiol—osteoporosis	0.000426	0.000616	CcSEcCtD
Tizanidine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000425	0.000614	CcSEcCtD
Tizanidine—Asthenia—Ibandronate—osteoporosis	0.000425	0.000613	CcSEcCtD
Tizanidine—Anxiety—Conjugated Estrogens—osteoporosis	0.000424	0.000612	CcSEcCtD
Tizanidine—Nausea—Etidronic acid—osteoporosis	0.000424	0.000612	CcSEcCtD
Tizanidine—Oedema—Zoledronate—osteoporosis	0.000423	0.000612	CcSEcCtD
Tizanidine—Anaphylactic shock—Zoledronate—osteoporosis	0.000423	0.000612	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000422	0.00061	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000422	0.00061	CcSEcCtD
Tizanidine—Diarrhoea—Estropipate—osteoporosis	0.000422	0.00061	CcSEcCtD
Tizanidine—Infection—Zoledronate—osteoporosis	0.000421	0.000608	CcSEcCtD
Tizanidine—Fatigue—Risedronate—osteoporosis	0.00042	0.000607	CcSEcCtD
Tizanidine—Pruritus—Ibandronate—osteoporosis	0.000419	0.000605	CcSEcCtD
Tizanidine—Constipation—Risedronate—osteoporosis	0.000417	0.000602	CcSEcCtD
Tizanidine—Angiopathy—Estradiol—osteoporosis	0.000417	0.000602	CcSEcCtD
Tizanidine—Shock—Zoledronate—osteoporosis	0.000417	0.000602	CcSEcCtD
Tizanidine—Paraesthesia—Pamidronate—osteoporosis	0.000416	0.000601	CcSEcCtD
Tizanidine—Diarrhoea—Alendronate—osteoporosis	0.000416	0.000601	CcSEcCtD
Tizanidine—Asthenia—Calcitriol—osteoporosis	0.000416	0.0006	CcSEcCtD
Tizanidine—Nervous system disorder—Zoledronate—osteoporosis	0.000415	0.0006	CcSEcCtD
Tizanidine—Immune system disorder—Estradiol—osteoporosis	0.000415	0.000599	CcSEcCtD
Tizanidine—Thrombocytopenia—Zoledronate—osteoporosis	0.000415	0.000599	CcSEcCtD
Tizanidine—Mediastinal disorder—Estradiol—osteoporosis	0.000414	0.000598	CcSEcCtD
Tizanidine—Dyspnoea—Pamidronate—osteoporosis	0.000413	0.000597	CcSEcCtD
Tizanidine—Tachycardia—Zoledronate—osteoporosis	0.000413	0.000597	CcSEcCtD
Tizanidine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000412	0.000595	CcSEcCtD
Tizanidine—Somnolence—Pamidronate—osteoporosis	0.000412	0.000595	CcSEcCtD
Tizanidine—Skin disorder—Zoledronate—osteoporosis	0.000411	0.000594	CcSEcCtD
Tizanidine—Pruritus—Calcitriol—osteoporosis	0.00041	0.000592	CcSEcCtD
Tizanidine—Hyperhidrosis—Zoledronate—osteoporosis	0.000409	0.000591	CcSEcCtD
Tizanidine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000409	0.000591	CcSEcCtD
Tizanidine—Diarrhoea—Raloxifene—osteoporosis	0.000409	0.000591	CcSEcCtD
Tizanidine—Dyspepsia—Pamidronate—osteoporosis	0.000408	0.000589	CcSEcCtD
Tizanidine—Dizziness—Estropipate—osteoporosis	0.000408	0.000589	CcSEcCtD
Tizanidine—Oedema—Conjugated Estrogens—osteoporosis	0.000408	0.000589	CcSEcCtD
Tizanidine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000408	0.000589	CcSEcCtD
Tizanidine—Alopecia—Estradiol—osteoporosis	0.000406	0.000586	CcSEcCtD
Tizanidine—Infection—Conjugated Estrogens—osteoporosis	0.000405	0.000585	CcSEcCtD
Tizanidine—Diarrhoea—Ibandronate—osteoporosis	0.000405	0.000585	CcSEcCtD
Tizanidine—Mental disorder—Estradiol—osteoporosis	0.000402	0.000581	CcSEcCtD
Tizanidine—Dizziness—Alendronate—osteoporosis	0.000402	0.000581	CcSEcCtD
Tizanidine—Shock—Conjugated Estrogens—osteoporosis	0.000401	0.000579	CcSEcCtD
Tizanidine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.0004	0.000578	CcSEcCtD
Tizanidine—Fatigue—Pamidronate—osteoporosis	0.0004	0.000577	CcSEcCtD
Tizanidine—Gastrointestinal pain—Risedronate—osteoporosis	0.000399	0.000576	CcSEcCtD
Tizanidine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000398	0.000575	CcSEcCtD
Tizanidine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000397	0.000574	CcSEcCtD
Tizanidine—Constipation—Pamidronate—osteoporosis	0.000396	0.000573	CcSEcCtD
Tizanidine—Diarrhoea—Calcitriol—osteoporosis	0.000396	0.000572	CcSEcCtD
Tizanidine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000396	0.000572	CcSEcCtD
Tizanidine—Hypotension—Zoledronate—osteoporosis	0.000396	0.000572	CcSEcCtD
Tizanidine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000395	0.000571	CcSEcCtD
Tizanidine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000395	0.000571	CcSEcCtD
Tizanidine—Dizziness—Raloxifene—osteoporosis	0.000395	0.000571	CcSEcCtD
Tizanidine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000394	0.000569	CcSEcCtD
Tizanidine—Flatulence—Estradiol—osteoporosis	0.000394	0.000569	CcSEcCtD
Tizanidine—Tension—Estradiol—osteoporosis	0.000392	0.000567	CcSEcCtD
Tizanidine—Vomiting—Estropipate—osteoporosis	0.000392	0.000567	CcSEcCtD
Tizanidine—Dizziness—Ibandronate—osteoporosis	0.000391	0.000565	CcSEcCtD
Tizanidine—Rash—Estropipate—osteoporosis	0.000389	0.000562	CcSEcCtD
Tizanidine—Dermatitis—Estropipate—osteoporosis	0.000389	0.000561	CcSEcCtD
Tizanidine—Nervousness—Estradiol—osteoporosis	0.000388	0.000561	CcSEcCtD
Tizanidine—Urticaria—Risedronate—osteoporosis	0.000387	0.00056	CcSEcCtD
Tizanidine—Back pain—Estradiol—osteoporosis	0.000387	0.000559	CcSEcCtD
Tizanidine—Vomiting—Alendronate—osteoporosis	0.000386	0.000558	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000386	0.000557	CcSEcCtD
Tizanidine—Abdominal pain—Risedronate—osteoporosis	0.000386	0.000557	CcSEcCtD
Tizanidine—Body temperature increased—Risedronate—osteoporosis	0.000386	0.000557	CcSEcCtD
Tizanidine—Muscle spasms—Estradiol—osteoporosis	0.000384	0.000555	CcSEcCtD
Tizanidine—Rash—Alendronate—osteoporosis	0.000383	0.000554	CcSEcCtD
Tizanidine—Dermatitis—Alendronate—osteoporosis	0.000383	0.000553	CcSEcCtD
Tizanidine—Feeling abnormal—Pamidronate—osteoporosis	0.000382	0.000552	CcSEcCtD
Tizanidine—Hypotension—Conjugated Estrogens—osteoporosis	0.000381	0.00055	CcSEcCtD
Tizanidine—Paraesthesia—Zoledronate—osteoporosis	0.00038	0.000549	CcSEcCtD
Tizanidine—Vomiting—Raloxifene—osteoporosis	0.00038	0.000549	CcSEcCtD
Tizanidine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000379	0.000548	CcSEcCtD
Tizanidine—Dyspnoea—Zoledronate—osteoporosis	0.000378	0.000545	CcSEcCtD
Tizanidine—Rash—Raloxifene—osteoporosis	0.000377	0.000544	CcSEcCtD
Tizanidine—Dermatitis—Raloxifene—osteoporosis	0.000377	0.000544	CcSEcCtD
Tizanidine—Somnolence—Zoledronate—osteoporosis	0.000376	0.000544	CcSEcCtD
Tizanidine—Vomiting—Ibandronate—osteoporosis	0.000376	0.000543	CcSEcCtD
Tizanidine—Tremor—Estradiol—osteoporosis	0.000375	0.000541	CcSEcCtD
Tizanidine—Rash—Ibandronate—osteoporosis	0.000373	0.000539	CcSEcCtD
Tizanidine—Dermatitis—Ibandronate—osteoporosis	0.000373	0.000538	CcSEcCtD
Tizanidine—Dyspepsia—Zoledronate—osteoporosis	0.000373	0.000538	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000371	0.000537	CcSEcCtD
Tizanidine—Ill-defined disorder—Estradiol—osteoporosis	0.000371	0.000536	CcSEcCtD
Tizanidine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000369	0.000532	CcSEcCtD
Tizanidine—Vomiting—Calcitriol—osteoporosis	0.000368	0.000532	CcSEcCtD
Tizanidine—Agitation—Estradiol—osteoporosis	0.000367	0.000531	CcSEcCtD
Tizanidine—Nausea—Estropipate—osteoporosis	0.000367	0.000529	CcSEcCtD
Tizanidine—Abdominal pain—Pamidronate—osteoporosis	0.000366	0.000529	CcSEcCtD
Tizanidine—Body temperature increased—Pamidronate—osteoporosis	0.000366	0.000529	CcSEcCtD
Tizanidine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000366	0.000529	CcSEcCtD
Tizanidine—Rash—Calcitriol—osteoporosis	0.000365	0.000528	CcSEcCtD
Tizanidine—Fatigue—Zoledronate—osteoporosis	0.000365	0.000527	CcSEcCtD
Tizanidine—Dermatitis—Calcitriol—osteoporosis	0.000365	0.000527	CcSEcCtD
Tizanidine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000364	0.000525	CcSEcCtD
Tizanidine—Somnolence—Conjugated Estrogens—osteoporosis	0.000362	0.000524	CcSEcCtD
Tizanidine—Constipation—Zoledronate—osteoporosis	0.000362	0.000523	CcSEcCtD
Tizanidine—Nausea—Alendronate—osteoporosis	0.000361	0.000521	CcSEcCtD
Tizanidine—Malaise—Estradiol—osteoporosis	0.000361	0.000521	CcSEcCtD
Tizanidine—Hypersensitivity—Risedronate—osteoporosis	0.000359	0.000519	CcSEcCtD
Tizanidine—Vertigo—Estradiol—osteoporosis	0.000359	0.000519	CcSEcCtD
Tizanidine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000359	0.000518	CcSEcCtD
Tizanidine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000359	0.000518	CcSEcCtD
Tizanidine—Syncope—Estradiol—osteoporosis	0.000359	0.000518	CcSEcCtD
Tizanidine—Nausea—Raloxifene—osteoporosis	0.000355	0.000513	CcSEcCtD
Tizanidine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000354	0.000511	CcSEcCtD
Tizanidine—Fatigue—Conjugated Estrogens—osteoporosis	0.000352	0.000508	CcSEcCtD
Tizanidine—Nausea—Ibandronate—osteoporosis	0.000351	0.000508	CcSEcCtD
Tizanidine—Loss of consciousness—Estradiol—osteoporosis	0.000351	0.000508	CcSEcCtD
Tizanidine—Asthenia—Risedronate—osteoporosis	0.00035	0.000505	CcSEcCtD
Tizanidine—Feeling abnormal—Zoledronate—osteoporosis	0.000349	0.000504	CcSEcCtD
Tizanidine—Constipation—Conjugated Estrogens—osteoporosis	0.000349	0.000504	CcSEcCtD
Tizanidine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000346	0.0005	CcSEcCtD
Tizanidine—Hypertension—Estradiol—osteoporosis	0.000345	0.000499	CcSEcCtD
Tizanidine—Pruritus—Risedronate—osteoporosis	0.000345	0.000498	CcSEcCtD
Tizanidine—Nausea—Calcitriol—osteoporosis	0.000344	0.000497	CcSEcCtD
Tizanidine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000342	0.000494	CcSEcCtD
Tizanidine—Hypersensitivity—Pamidronate—osteoporosis	0.000342	0.000493	CcSEcCtD
Tizanidine—Arthralgia—Estradiol—osteoporosis	0.00034	0.000492	CcSEcCtD
Tizanidine—Anxiety—Estradiol—osteoporosis	0.000339	0.00049	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000338	0.000488	CcSEcCtD
Tizanidine—Urticaria—Zoledronate—osteoporosis	0.000336	0.000486	CcSEcCtD
Tizanidine—Discomfort—Estradiol—osteoporosis	0.000336	0.000486	CcSEcCtD
Tizanidine—Abdominal pain—Zoledronate—osteoporosis	0.000335	0.000483	CcSEcCtD
Tizanidine—Body temperature increased—Zoledronate—osteoporosis	0.000335	0.000483	CcSEcCtD
Tizanidine—Diarrhoea—Risedronate—osteoporosis	0.000334	0.000482	CcSEcCtD
Tizanidine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000333	0.000482	CcSEcCtD
Tizanidine—Dry mouth—Estradiol—osteoporosis	0.000333	0.000481	CcSEcCtD
Tizanidine—Asthenia—Pamidronate—osteoporosis	0.000333	0.00048	CcSEcCtD
Tizanidine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000331	0.000478	CcSEcCtD
Tizanidine—Confusional state—Estradiol—osteoporosis	0.000329	0.000475	CcSEcCtD
Tizanidine—Pruritus—Pamidronate—osteoporosis	0.000328	0.000474	CcSEcCtD
Tizanidine—Anaphylactic shock—Estradiol—osteoporosis	0.000326	0.000471	CcSEcCtD
Tizanidine—Oedema—Estradiol—osteoporosis	0.000326	0.000471	CcSEcCtD
Tizanidine—Infection—Estradiol—osteoporosis	0.000324	0.000468	CcSEcCtD
Tizanidine—Urticaria—Conjugated Estrogens—osteoporosis	0.000324	0.000468	CcSEcCtD
Tizanidine—Dizziness—Risedronate—osteoporosis	0.000322	0.000466	CcSEcCtD
Tizanidine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000322	0.000466	CcSEcCtD
Tizanidine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000322	0.000466	CcSEcCtD
Tizanidine—Shock—Estradiol—osteoporosis	0.000321	0.000464	CcSEcCtD
Tizanidine—Nervous system disorder—Estradiol—osteoporosis	0.00032	0.000462	CcSEcCtD
Tizanidine—Tachycardia—Estradiol—osteoporosis	0.000318	0.00046	CcSEcCtD
Tizanidine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000318	0.000459	CcSEcCtD
Tizanidine—Diarrhoea—Pamidronate—osteoporosis	0.000317	0.000458	CcSEcCtD
Tizanidine—Skin disorder—Estradiol—osteoporosis	0.000317	0.000458	CcSEcCtD
Tizanidine—Hyperhidrosis—Estradiol—osteoporosis	0.000315	0.000456	CcSEcCtD
Tizanidine—Rash—Ethinyl Estradiol—osteoporosis	0.000315	0.000456	CcSEcCtD
Tizanidine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000315	0.000455	CcSEcCtD
Tizanidine—Hypersensitivity—Zoledronate—osteoporosis	0.000312	0.000451	CcSEcCtD
Tizanidine—Vomiting—Risedronate—osteoporosis	0.00031	0.000448	CcSEcCtD
Tizanidine—Rash—Risedronate—osteoporosis	0.000307	0.000444	CcSEcCtD
Tizanidine—Dermatitis—Risedronate—osteoporosis	0.000307	0.000444	CcSEcCtD
Tizanidine—Dizziness—Pamidronate—osteoporosis	0.000307	0.000443	CcSEcCtD
Tizanidine—Asthenia—Zoledronate—osteoporosis	0.000304	0.000439	CcSEcCtD
Tizanidine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.0003	0.000434	CcSEcCtD
Tizanidine—Pruritus—Zoledronate—osteoporosis	0.0003	0.000433	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000297	0.000429	CcSEcCtD
Tizanidine—Nausea—Ethinyl Estradiol—osteoporosis	0.000297	0.000429	CcSEcCtD
Tizanidine—Vomiting—Pamidronate—osteoporosis	0.000295	0.000426	CcSEcCtD
Tizanidine—Paraesthesia—Estradiol—osteoporosis	0.000293	0.000423	CcSEcCtD
Tizanidine—Asthenia—Conjugated Estrogens—osteoporosis	0.000293	0.000423	CcSEcCtD
Tizanidine—Rash—Pamidronate—osteoporosis	0.000292	0.000422	CcSEcCtD
Tizanidine—Dermatitis—Pamidronate—osteoporosis	0.000292	0.000422	CcSEcCtD
Tizanidine—Dyspnoea—Estradiol—osteoporosis	0.000291	0.00042	CcSEcCtD
Tizanidine—Somnolence—Estradiol—osteoporosis	0.00029	0.000419	CcSEcCtD
Tizanidine—Diarrhoea—Zoledronate—osteoporosis	0.00029	0.000418	CcSEcCtD
Tizanidine—Nausea—Risedronate—osteoporosis	0.00029	0.000418	CcSEcCtD
Tizanidine—Pruritus—Conjugated Estrogens—osteoporosis	0.000288	0.000417	CcSEcCtD
Tizanidine—Dyspepsia—Estradiol—osteoporosis	0.000287	0.000415	CcSEcCtD
Tizanidine—Fatigue—Estradiol—osteoporosis	0.000281	0.000406	CcSEcCtD
Tizanidine—Dizziness—Zoledronate—osteoporosis	0.00028	0.000404	CcSEcCtD
Tizanidine—Constipation—Estradiol—osteoporosis	0.000279	0.000403	CcSEcCtD
Tizanidine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000279	0.000403	CcSEcCtD
Tizanidine—Nausea—Pamidronate—osteoporosis	0.000275	0.000398	CcSEcCtD
Tizanidine—Dizziness—Conjugated Estrogens—osteoporosis	0.00027	0.000389	CcSEcCtD
Tizanidine—Vomiting—Zoledronate—osteoporosis	0.000269	0.000389	CcSEcCtD
Tizanidine—Feeling abnormal—Estradiol—osteoporosis	0.000269	0.000388	CcSEcCtD
Tizanidine—Rash—Zoledronate—osteoporosis	0.000267	0.000386	CcSEcCtD
Tizanidine—Gastrointestinal pain—Estradiol—osteoporosis	0.000267	0.000385	CcSEcCtD
Tizanidine—Dermatitis—Zoledronate—osteoporosis	0.000267	0.000385	CcSEcCtD
Tizanidine—Vomiting—Conjugated Estrogens—osteoporosis	0.000259	0.000374	CcSEcCtD
Tizanidine—Urticaria—Estradiol—osteoporosis	0.000259	0.000374	CcSEcCtD
Tizanidine—Body temperature increased—Estradiol—osteoporosis	0.000258	0.000373	CcSEcCtD
Tizanidine—Abdominal pain—Estradiol—osteoporosis	0.000258	0.000373	CcSEcCtD
Tizanidine—Rash—Conjugated Estrogens—osteoporosis	0.000257	0.000371	CcSEcCtD
Tizanidine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000257	0.000371	CcSEcCtD
Tizanidine—Nausea—Zoledronate—osteoporosis	0.000252	0.000363	CcSEcCtD
Tizanidine—Nausea—Conjugated Estrogens—osteoporosis	0.000242	0.00035	CcSEcCtD
Tizanidine—Hypersensitivity—Estradiol—osteoporosis	0.00024	0.000347	CcSEcCtD
Tizanidine—Asthenia—Estradiol—osteoporosis	0.000234	0.000338	CcSEcCtD
Tizanidine—Pruritus—Estradiol—osteoporosis	0.000231	0.000333	CcSEcCtD
Tizanidine—Diarrhoea—Estradiol—osteoporosis	0.000223	0.000322	CcSEcCtD
Tizanidine—Dizziness—Estradiol—osteoporosis	0.000216	0.000312	CcSEcCtD
Tizanidine—Vomiting—Estradiol—osteoporosis	0.000207	0.0003	CcSEcCtD
Tizanidine—Rash—Estradiol—osteoporosis	0.000206	0.000297	CcSEcCtD
Tizanidine—Dermatitis—Estradiol—osteoporosis	0.000206	0.000297	CcSEcCtD
Tizanidine—Nausea—Estradiol—osteoporosis	0.000194	0.00028	CcSEcCtD
Tizanidine—ADRA2C—Metabolism—PNP—osteoporosis	0.000133	0.00175	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—FGA—osteoporosis	0.00013	0.00171	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SOST—osteoporosis	0.000129	0.00169	CbGpPWpGaD
Tizanidine—ADRA2C—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000128	0.00169	CbGpPWpGaD
Tizanidine—ADRA2C—G alpha (i) signalling events—POMC—osteoporosis	0.000127	0.00167	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—MGLL—osteoporosis	0.000127	0.00167	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—FDPS—osteoporosis	0.000125	0.00164	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PKM—osteoporosis	0.000125	0.00164	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PTH1R—osteoporosis	0.000124	0.00164	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CALCR—osteoporosis	0.000124	0.00164	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PTH—osteoporosis	0.000122	0.0016	CbGpPWpGaD
Tizanidine—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	0.000122	0.0016	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.000121	0.0016	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000121	0.00159	CbGpPWpGaD
Tizanidine—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	0.00012	0.00158	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—CALCA—osteoporosis	0.000119	0.00157	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CNR2—osteoporosis	0.000119	0.00156	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—FGB—osteoporosis	0.000119	0.00156	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PGLS—osteoporosis	0.000118	0.00156	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GPD2—osteoporosis	0.000118	0.00156	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CALCR—osteoporosis	0.000116	0.00153	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PTH1R—osteoporosis	0.000116	0.00153	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000114	0.0015	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PTH—osteoporosis	0.000114	0.0015	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CA2—osteoporosis	0.000113	0.00149	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—OXCT1—osteoporosis	0.000113	0.00149	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	0.000113	0.00149	CbGpPWpGaD
Tizanidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	0.000113	0.00149	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000111	0.00146	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CNR2—osteoporosis	0.000111	0.00146	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PTH—osteoporosis	0.000111	0.00146	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—MGLL—osteoporosis	0.00011	0.00145	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PNP—osteoporosis	0.000108	0.00142	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ATIC—osteoporosis	0.000108	0.00142	CbGpPWpGaD
Tizanidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000108	0.00142	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CNR2—osteoporosis	0.000108	0.00142	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SOST—osteoporosis	0.000104	0.00137	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000104	0.00137	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PTH—osteoporosis	0.000103	0.00136	CbGpPWpGaD
Tizanidine—ADRA2A—G alpha (i) signalling events—POMC—osteoporosis	0.000103	0.00136	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—WNT1—osteoporosis	0.000101	0.00133	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PTHLH—osteoporosis	0.000101	0.00133	CbGpPWpGaD
Tizanidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000101	0.00133	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CNR2—osteoporosis	0.000101	0.00132	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MGLL—osteoporosis	9.89e-05	0.0013	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—LRP5—osteoporosis	9.65e-05	0.00127	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—WNT1—osteoporosis	9.47e-05	0.00125	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PTH1R—osteoporosis	9.44e-05	0.00124	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CALCR—osteoporosis	9.44e-05	0.00124	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PTHLH—osteoporosis	9.43e-05	0.00124	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—IDH2—osteoporosis	9.39e-05	0.00123	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PTH—osteoporosis	9.25e-05	0.00122	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MGLL—osteoporosis	9.24e-05	0.00121	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—LRP6—osteoporosis	9.23e-05	0.00121	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—OXCT1—osteoporosis	9.21e-05	0.00121	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CA2—osteoporosis	9.21e-05	0.00121	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PTHLH—osteoporosis	9.17e-05	0.00121	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—LRP5—osteoporosis	9.01e-05	0.00119	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CNR2—osteoporosis	9.01e-05	0.00118	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—MGLL—osteoporosis	8.97e-05	0.00118	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CALCA—osteoporosis	8.89e-05	0.00117	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.89e-05	0.00117	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CYP27A1—osteoporosis	8.83e-05	0.00116	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—LRP6—osteoporosis	8.62e-05	0.00113	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ACP5—osteoporosis	8.59e-05	0.00113	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PTHLH—osteoporosis	8.57e-05	0.00113	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PTH—osteoporosis	8.4e-05	0.0011	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CALCA—osteoporosis	8.3e-05	0.00109	CbGpPWpGaD
Tizanidine—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	8.23e-05	0.00108	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR ligand binding—POMC—osteoporosis	8.23e-05	0.00108	CbGpPWpGaD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	8.2e-05	0.00108	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CNR2—osteoporosis	8.18e-05	0.00108	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CALCA—osteoporosis	8.07e-05	0.00106	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—TPI1—osteoporosis	7.99e-05	0.00105	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TLN1—osteoporosis	7.79e-05	0.00102	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—WNT1—osteoporosis	7.69e-05	0.00101	CbGpPWpGaD
Tizanidine—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	7.69e-05	0.00101	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—POMC—osteoporosis	7.69e-05	0.00101	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PTHLH—osteoporosis	7.66e-05	0.00101	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—IDH2—osteoporosis	7.63e-05	0.001	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.56e-05	0.000994	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CALCA—osteoporosis	7.54e-05	0.000992	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—P4HB—osteoporosis	7.51e-05	0.000987	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MGLL—osteoporosis	7.5e-05	0.000986	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GAPDH—osteoporosis	7.37e-05	0.000969	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LRP5—osteoporosis	7.32e-05	0.000963	CbGpPWpGaD
Tizanidine—CYP1A2—Biological oxidations—POMC—osteoporosis	7.31e-05	0.000961	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TLN1—osteoporosis	7.28e-05	0.000957	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—RAP1A—osteoporosis	7.18e-05	0.000944	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP27A1—osteoporosis	7.17e-05	0.000943	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—IGF1—osteoporosis	7.08e-05	0.000931	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LRP6—osteoporosis	7e-05	0.000921	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ACP5—osteoporosis	6.98e-05	0.000917	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PTHLH—osteoporosis	6.96e-05	0.000915	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PKM—osteoporosis	6.89e-05	0.000906	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—FDPS—osteoporosis	6.89e-05	0.000906	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CALCA—osteoporosis	6.75e-05	0.000887	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—P4HB—osteoporosis	6.72e-05	0.000884	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—IGF1—osteoporosis	6.61e-05	0.00087	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PTH—osteoporosis	6.54e-05	0.00086	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PGLS—osteoporosis	6.53e-05	0.000859	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GPD2—osteoporosis	6.53e-05	0.000859	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—TPI1—osteoporosis	6.49e-05	0.000853	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RAP1A—osteoporosis	6.42e-05	0.000845	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CNR2—osteoporosis	6.37e-05	0.000838	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—ADCY5—osteoporosis	6.32e-05	0.000832	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—P4HB—osteoporosis	6.28e-05	0.000825	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NFATC1—osteoporosis	6.27e-05	0.000824	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	6.25e-05	0.000821	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—POMC—osteoporosis	6.24e-05	0.000821	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—DKK1—osteoporosis	6.22e-05	0.000818	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CALCA—osteoporosis	6.13e-05	0.000805	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PTH—osteoporosis	6.11e-05	0.000803	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—P4HB—osteoporosis	6.1e-05	0.000802	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RAP1A—osteoporosis	6e-05	0.000789	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—WNT1—osteoporosis	5.99e-05	0.000788	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GAPDH—osteoporosis	5.99e-05	0.000787	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PNP—osteoporosis	5.98e-05	0.000786	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ATIC—osteoporosis	5.98e-05	0.000786	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CNR2—osteoporosis	5.95e-05	0.000783	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TLN1—osteoporosis	5.91e-05	0.000778	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—ADCY5—osteoporosis	5.91e-05	0.000777	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NFATC1—osteoporosis	5.85e-05	0.00077	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—RAP1A—osteoporosis	5.83e-05	0.000767	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FGA—osteoporosis	5.83e-05	0.000766	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—DKK1—osteoporosis	5.81e-05	0.000764	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ENO1—osteoporosis	5.8e-05	0.000763	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—ADCY5—osteoporosis	5.74e-05	0.000755	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PSMA2—osteoporosis	5.72e-05	0.000752	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PSMA5—osteoporosis	5.72e-05	0.000752	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—WNT1—osteoporosis	5.6e-05	0.000736	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FGA—osteoporosis	5.44e-05	0.000716	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PTHLH—osteoporosis	5.42e-05	0.000712	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—BMP2—osteoporosis	5.42e-05	0.000712	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—IGF1—osteoporosis	5.37e-05	0.000706	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—ADCY5—osteoporosis	5.36e-05	0.000705	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FGB—osteoporosis	5.3e-05	0.000697	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PSMA2—osteoporosis	5.12e-05	0.000673	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PSMA5—osteoporosis	5.12e-05	0.000673	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—P4HB—osteoporosis	5.1e-05	0.00067	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CA2—osteoporosis	5.08e-05	0.000668	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—OXCT1—osteoporosis	5.08e-05	0.000668	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PTHLH—osteoporosis	5.06e-05	0.000665	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—BMP2—osteoporosis	5.06e-05	0.000665	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PTH—osteoporosis	4.96e-05	0.000652	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—MGLL—osteoporosis	4.95e-05	0.000651	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FGB—osteoporosis	4.95e-05	0.000651	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	4.87e-05	0.000641	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CNR2—osteoporosis	4.83e-05	0.000636	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	4.8e-05	0.000631	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PSMA2—osteoporosis	4.78e-05	0.000629	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PSMA5—osteoporosis	4.78e-05	0.000629	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CALCA—osteoporosis	4.77e-05	0.000627	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	4.76e-05	0.000625	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—DKK1—osteoporosis	4.72e-05	0.00062	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ENO1—osteoporosis	4.71e-05	0.00062	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.67e-05	0.000614	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—POMC—osteoporosis	4.65e-05	0.000612	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PSMA2—osteoporosis	4.64e-05	0.000611	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PSMA5—osteoporosis	4.64e-05	0.000611	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CYP19A1—osteoporosis	4.64e-05	0.00061	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—WNT1—osteoporosis	4.54e-05	0.000598	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CALCA—osteoporosis	4.45e-05	0.000586	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FGA—osteoporosis	4.42e-05	0.000581	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	4.36e-05	0.000573	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—POMC—osteoporosis	4.34e-05	0.000571	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KL—osteoporosis	4.33e-05	0.000569	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—TGFB1—osteoporosis	4.24e-05	0.000558	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—POMC—osteoporosis	4.22e-05	0.000555	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—IDH2—osteoporosis	4.21e-05	0.000554	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL6R—osteoporosis	4.12e-05	0.000542	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	4.11e-05	0.00054	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—BMP2—osteoporosis	4.11e-05	0.00054	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KL—osteoporosis	4.05e-05	0.000532	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FGB—osteoporosis	4.02e-05	0.000529	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—TGFB1—osteoporosis	3.96e-05	0.000521	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP27A1—osteoporosis	3.96e-05	0.000521	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—POMC—osteoporosis	3.95e-05	0.000519	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	3.88e-05	0.000511	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	3.88e-05	0.000511	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ACP5—osteoporosis	3.85e-05	0.000506	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL6R—osteoporosis	3.85e-05	0.000506	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.8e-05	0.0005	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ADCY5—osteoporosis	3.79e-05	0.000498	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GPX1—osteoporosis	3.78e-05	0.000497	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP19A1—osteoporosis	3.77e-05	0.000495	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CALCA—osteoporosis	3.62e-05	0.000476	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—TPI1—osteoporosis	3.58e-05	0.000471	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	3.53e-05	0.000464	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—MTHFR—osteoporosis	3.49e-05	0.000458	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	3.39e-05	0.000446	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—P4HB—osteoporosis	3.37e-05	0.000443	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GAPDH—osteoporosis	3.3e-05	0.000434	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KL—osteoporosis	3.29e-05	0.000432	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SPP1—osteoporosis	3.28e-05	0.000432	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TGFB1—osteoporosis	3.22e-05	0.000423	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—RAP1A—osteoporosis	3.22e-05	0.000423	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	3.2e-05	0.000421	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	3.17e-05	0.000417	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	3.13e-05	0.000411	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ADCY5—osteoporosis	3.08e-05	0.000405	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GPX1—osteoporosis	3.07e-05	0.000403	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SPP1—osteoporosis	3.07e-05	0.000403	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IRS2—osteoporosis	2.97e-05	0.00039	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—LEP—osteoporosis	2.9e-05	0.000382	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—MTHFR—osteoporosis	2.83e-05	0.000372	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.81e-05	0.000369	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—POMC—osteoporosis	2.79e-05	0.000367	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ESR1—osteoporosis	2.77e-05	0.000365	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IRS2—osteoporosis	2.77e-05	0.000365	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—LEP—osteoporosis	2.71e-05	0.000357	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ENO1—osteoporosis	2.6e-05	0.000342	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IRS1—osteoporosis	2.59e-05	0.000341	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ESR1—osteoporosis	2.59e-05	0.000341	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	2.57e-05	0.000338	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PSMA5—osteoporosis	2.56e-05	0.000337	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PSMA2—osteoporosis	2.56e-05	0.000337	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—POMC—osteoporosis	2.5e-05	0.000328	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	2.49e-05	0.000327	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6R—osteoporosis	2.43e-05	0.00032	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IRS1—osteoporosis	2.42e-05	0.000318	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IGF1—osteoporosis	2.4e-05	0.000316	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—POMC—osteoporosis	2.33e-05	0.000306	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6R—osteoporosis	2.27e-05	0.000299	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—POMC—osteoporosis	2.26e-05	0.000298	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	2.25e-05	0.000296	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IGF1—osteoporosis	2.24e-05	0.000295	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LEP—osteoporosis	2.2e-05	0.00029	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	2.1e-05	0.000277	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP19A1—osteoporosis	2.08e-05	0.000273	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	1.97e-05	0.000259	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—POMC—osteoporosis	1.89e-05	0.000249	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	1.85e-05	0.000243	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL6—osteoporosis	1.84e-05	0.000241	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	1.82e-05	0.000239	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL6—osteoporosis	1.71e-05	0.000225	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ADCY5—osteoporosis	1.7e-05	0.000223	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GPX1—osteoporosis	1.69e-05	0.000223	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—MTHFR—osteoporosis	1.56e-05	0.000205	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MYC—osteoporosis	1.44e-05	0.00019	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	1.44e-05	0.000189	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	1.39e-05	0.000183	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MYC—osteoporosis	1.35e-05	0.000177	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	1.34e-05	0.000177	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—POMC—osteoporosis	1.25e-05	0.000164	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MYC—osteoporosis	1.09e-05	0.000144	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	1.09e-05	0.000144	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6—osteoporosis	1.08e-05	0.000143	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6—osteoporosis	1.01e-05	0.000133	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6—osteoporosis	8.23e-06	0.000108	CbGpPWpGaD
